Update: UK moves to cut three months or more off time it takes to deal with drug "switching" requests
This article was originally published in SRA
Improved procedures at the Medicines and Healthcare products Regulatory Agency in the UK should cut around three months off the time it takes the agency to process applications from drug companies to change the legal classification status of their medicines, for example from prescription-only to pharmacy or from pharmacy to general sales1. Even greater improvements are expected for more challenging "switch" applications, some of which in the past have taken more than two years to complete2.
You may also be interested in...
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."